Evidence for smoking cessation

Implications for gender-specific strategies

Joanne K. Singleton, Rona F. Levin, Harriet R. Feldman, Marie Truglio-Londrigan

Research output: Contribution to journalArticle

Abstract

Background: Facilitating smoking cessation requires an evidence-based approach. The Lienhard School of Nursing Institute for Healthy Aging in the United States, whose focus is providing health information to aging baby boomers, developed an interest in studying strategies for smoking cessation in women. Approach: Studies were reviewed and critiqued related to the question: What is the relative efficacy of first-line smoking cessation interventions for women versus men in the 40- to 65-year-old age group? This article first discusses the procedure used to construct an integrative framework for finding the evidence on smoking cessation, including a literature search and refinement of the problem to be studied, and then a summary of the evidence gathered on the selected variable (gender) and interventions (counseling, pharmacotherapy nicotine replacement therapy). Findings: Evidence was found that supports the general efficacy of three first-line smoking cessation interventions: counseling, bupropion-sustained release (BSR), and nicotine replacement therapy (NRT). What the evidence does not show, however, is which of these interventions may be more effective for women versus men in general or specifically in the 40- to 65-year-old age group. Recommendations: Recommendations include the development of a clinical trial and the inclusion from the outset of gender as a major variable in all future intervention studies. Implications: Practice implications include the fact that since effective treatments already exist for assisting clients to stop smoking, all health-care providers should offer an intervention that has been found effective to any client who expresses a desire to quit smoking. Further studies of efficacy are needed to develop more focused implications.

Original languageEnglish (US)
Pages (from-to)63-74
Number of pages12
JournalWorldviews on Evidence-Based Nursing
Volume2
Issue number2
DOIs
StatePublished - Jun 2005

Fingerprint

Smoking Cessation
Nicotine
Counseling
Age Groups
Smoking
Bupropion
School Nursing
Health Personnel
Therapeutics
Clinical Trials
Drug Therapy
Health

Keywords

  • Evidence-based practice
  • Smoking cessation
  • Women

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Evidence for smoking cessation : Implications for gender-specific strategies. / Singleton, Joanne K.; Levin, Rona F.; Feldman, Harriet R.; Truglio-Londrigan, Marie.

In: Worldviews on Evidence-Based Nursing, Vol. 2, No. 2, 06.2005, p. 63-74.

Research output: Contribution to journalArticle

Singleton, Joanne K. ; Levin, Rona F. ; Feldman, Harriet R. ; Truglio-Londrigan, Marie. / Evidence for smoking cessation : Implications for gender-specific strategies. In: Worldviews on Evidence-Based Nursing. 2005 ; Vol. 2, No. 2. pp. 63-74.
@article{b9cb040347de479cb324462a61c72281,
title = "Evidence for smoking cessation: Implications for gender-specific strategies",
abstract = "Background: Facilitating smoking cessation requires an evidence-based approach. The Lienhard School of Nursing Institute for Healthy Aging in the United States, whose focus is providing health information to aging baby boomers, developed an interest in studying strategies for smoking cessation in women. Approach: Studies were reviewed and critiqued related to the question: What is the relative efficacy of first-line smoking cessation interventions for women versus men in the 40- to 65-year-old age group? This article first discusses the procedure used to construct an integrative framework for finding the evidence on smoking cessation, including a literature search and refinement of the problem to be studied, and then a summary of the evidence gathered on the selected variable (gender) and interventions (counseling, pharmacotherapy nicotine replacement therapy). Findings: Evidence was found that supports the general efficacy of three first-line smoking cessation interventions: counseling, bupropion-sustained release (BSR), and nicotine replacement therapy (NRT). What the evidence does not show, however, is which of these interventions may be more effective for women versus men in general or specifically in the 40- to 65-year-old age group. Recommendations: Recommendations include the development of a clinical trial and the inclusion from the outset of gender as a major variable in all future intervention studies. Implications: Practice implications include the fact that since effective treatments already exist for assisting clients to stop smoking, all health-care providers should offer an intervention that has been found effective to any client who expresses a desire to quit smoking. Further studies of efficacy are needed to develop more focused implications.",
keywords = "Evidence-based practice, Smoking cessation, Women",
author = "Singleton, {Joanne K.} and Levin, {Rona F.} and Feldman, {Harriet R.} and Marie Truglio-Londrigan",
year = "2005",
month = "6",
doi = "10.1111/j.1741-6787.2005.04055.x",
language = "English (US)",
volume = "2",
pages = "63--74",
journal = "Worldviews on Evidence-Based Nursing",
issn = "1545-102X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Evidence for smoking cessation

T2 - Implications for gender-specific strategies

AU - Singleton, Joanne K.

AU - Levin, Rona F.

AU - Feldman, Harriet R.

AU - Truglio-Londrigan, Marie

PY - 2005/6

Y1 - 2005/6

N2 - Background: Facilitating smoking cessation requires an evidence-based approach. The Lienhard School of Nursing Institute for Healthy Aging in the United States, whose focus is providing health information to aging baby boomers, developed an interest in studying strategies for smoking cessation in women. Approach: Studies were reviewed and critiqued related to the question: What is the relative efficacy of first-line smoking cessation interventions for women versus men in the 40- to 65-year-old age group? This article first discusses the procedure used to construct an integrative framework for finding the evidence on smoking cessation, including a literature search and refinement of the problem to be studied, and then a summary of the evidence gathered on the selected variable (gender) and interventions (counseling, pharmacotherapy nicotine replacement therapy). Findings: Evidence was found that supports the general efficacy of three first-line smoking cessation interventions: counseling, bupropion-sustained release (BSR), and nicotine replacement therapy (NRT). What the evidence does not show, however, is which of these interventions may be more effective for women versus men in general or specifically in the 40- to 65-year-old age group. Recommendations: Recommendations include the development of a clinical trial and the inclusion from the outset of gender as a major variable in all future intervention studies. Implications: Practice implications include the fact that since effective treatments already exist for assisting clients to stop smoking, all health-care providers should offer an intervention that has been found effective to any client who expresses a desire to quit smoking. Further studies of efficacy are needed to develop more focused implications.

AB - Background: Facilitating smoking cessation requires an evidence-based approach. The Lienhard School of Nursing Institute for Healthy Aging in the United States, whose focus is providing health information to aging baby boomers, developed an interest in studying strategies for smoking cessation in women. Approach: Studies were reviewed and critiqued related to the question: What is the relative efficacy of first-line smoking cessation interventions for women versus men in the 40- to 65-year-old age group? This article first discusses the procedure used to construct an integrative framework for finding the evidence on smoking cessation, including a literature search and refinement of the problem to be studied, and then a summary of the evidence gathered on the selected variable (gender) and interventions (counseling, pharmacotherapy nicotine replacement therapy). Findings: Evidence was found that supports the general efficacy of three first-line smoking cessation interventions: counseling, bupropion-sustained release (BSR), and nicotine replacement therapy (NRT). What the evidence does not show, however, is which of these interventions may be more effective for women versus men in general or specifically in the 40- to 65-year-old age group. Recommendations: Recommendations include the development of a clinical trial and the inclusion from the outset of gender as a major variable in all future intervention studies. Implications: Practice implications include the fact that since effective treatments already exist for assisting clients to stop smoking, all health-care providers should offer an intervention that has been found effective to any client who expresses a desire to quit smoking. Further studies of efficacy are needed to develop more focused implications.

KW - Evidence-based practice

KW - Smoking cessation

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=28244471639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28244471639&partnerID=8YFLogxK

U2 - 10.1111/j.1741-6787.2005.04055.x

DO - 10.1111/j.1741-6787.2005.04055.x

M3 - Article

VL - 2

SP - 63

EP - 74

JO - Worldviews on Evidence-Based Nursing

JF - Worldviews on Evidence-Based Nursing

SN - 1545-102X

IS - 2

ER -